SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-24-146054
Filing Date
2024-05-23
Accepted
2024-05-23 16:48:28
Documents
1
Effectiveness Date
2024-05-23

Document Format Files

Seq Description Document Type Size
1 S-8 POS d834244ds8pos.htm S-8 POS 22582
  Complete submission text file 0001193125-24-146054.txt   23622
Mailing Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060
Business Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060 540-818-2844
Landos Biopharma, Inc. (Filer) CIK: 0001785345 (see all company filings)

IRS No.: 815085535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-263832 | Film No.: 24979106
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)